Renato Salvador

Dr. Renato Salvador

Associate Professor, Department of Surgical, Oncological and Gastroenterological Sciences, School of Medicine, University of Padova, 35128 Padova, Italy
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2020 in Nature
Verified
Journal Article
Closed access
PDF file
Enrico LavezzoEnrico Lavezzo
Enrico Lavezzo
EFElisa Franchin
Elisa Franchin
CCConstanze Ciavarella
Constanze Ciavarella
GCGina Cuomo-Dannenburg
Gina Cuomo-Dannenburg
Luisa BarzonLuisa Barzon
Luisa Barzon
Andrea CrisantiAndrea Crisanti
Andrea Crisanti

1 January 2017 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
Renato SalvadorRenato Salvador
Renato Salvador
EPElisa Pesenti
Elisa Pesenti
LGLaura Gobbi
Laura Gobbi
GCGiovanni Capovilla
Giovanni Capovilla
LSLorenzo Spadotto
Lorenzo Spadotto
MCMario Costantini
Mario Costantini

23 February 2022 in World Journal of Surgery
Verified
Journal Article
Open access
PDF file
FRFederica Riccio
Federica Riccio
MCMario Costantini
Mario Costantini
Renato SalvadorRenato Salvador
Renato Salvador
A precise diagnosis is key to the successful treatment of achalasia. Barium swallow, upper endoscopy and high‐resolution manometry provide the necessary information about a patient's anatomy, absence of other diseases, and type of achalasia (I, II, III). High‐resolution manometry also has prognostic value, the best results of treatment being obtained in type II achalasia according to the Chicago classification. Abdominal CT scanning and endoscopic ultrasound might be warranted if an underlying malignancy is suspected.

1 April 2018 in Digestive and Liver Disease
Verified
Journal Article
Closed access
Renato SalvadorRenato Salvador
Renato Salvador
GVGuerrino Voltarel
Guerrino Voltarel
ESEdoardo Vincenzo Savarino
Edoardo Vincenzo Savarino
GCGiovanni Capovilla
Giovanni Capovilla
EPElisa Pesenti
Elisa Pesenti
MCMario Costantini
Mario Costantini

29 September 2016 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
Renato SalvadorRenato Salvador
Renato Salvador
LSLorenzo Spadotto
Lorenzo Spadotto
GCGiovanni Capovilla
Giovanni Capovilla
GVGuerrino Voltarel
Guerrino Voltarel
EPElisa Pesenti
Elisa Pesenti
MCMario Costantini
Mario Costantini

7 June 2021 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Open access
PDF file
GCGiovanni Capovilla
Giovanni Capovilla
Renato SalvadorRenato Salvador
Renato Salvador
LPLuca Provenzano
Luca Provenzano
MVMichele Valmasoni
Michele Valmasoni
LMLucia Moletta
Lucia Moletta
MCMario Costantini
Mario Costantini
Background Laparoscopic Heller myotomy (HM) has gained acceptance as the gold standard of treatment for achalasia. However, 10–20% of the patients will experience symptom recurrence, thus requiring further treatment including pneumodilations (PD) or revisional surgery. The aim of our study was to assess the long-term outcome of laparoscopic redo HM. Methods Patients who underwent redo HM at our center between 2000 and 2019 were enrolled. Postoperative outcomes of redo HM patients (redo group) were compared with that of patients who underwent primary laparoscopic HM in the same time span (control group). For the control group, we randomly selected patients matched for age, sex, FU time, Eckardt score (ES), previous PD, and radiological stage. Failure was defined as an Eckardt score > 3 or the need for re-treatment. Results Forty-nine patients underwent laparoscopic redo HM after failed primary HM. A new myotomy on the right lateral wall of the EGJ was the procedure of choice in the majority of patients (83.7%). In 36 patients (73.5%) an anti-reflux procedure was deemed necessary. Postoperative outcomes were somewhat less satisfactory, albeit comparable to the control group; the incidence of postoperative GERD was higher in the redo group (p < 0.01). At a median 5-year FU time, a good outcome was obtained in 71.4% of patients in the redo group; further 5 patients (10.2%) obtained a long-term symptom control after complementary PD, thus bringing the overall success rate to 81.6%. Stage IV disease at presentation was independently associated with a poor outcome of revisional LHD (p = 0.003). Conclusions This study reports the largest case series of laparoscopic redo HM to date. The procedure, albeit difficult, is safe and effective in relieving symptoms in this group of patients with a highly refractory disease. The failure rate, albeit not significantly, and the post-operative reflux are higher than after primary HM. Patients with stage IV disease are at high risk of esophagectomy.